Sino-Agri Leading Biosciences Co.,Ltd (SHA:603970)
China · Delayed Price · Currency is CNY 10.61
+0.25 (2.41%)
Aug 17, 2026, 3:00 PM CST
SHA:603970 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,852 | 3,457 | 3,817 | 4,129 | 5,626 | 5,002 | |
Market Cap Growth | -25.91% | -9.44% | -7.55% | -26.61% | 12.48% | 23.46% |
Enterprise Value | 2,547 | 4,520 | 3,816 | 3,979 | 4,568 | 5,811 |
Last Close Price | 10.61 | 12.48 | 13.37 | 14.11 | 18.85 | 16.58 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 16.44 | 20.04 | 18.77 | 18.36 | 26.75 | 29.37 |
Forward PE | - | 14.86 | 15.44 | 15.36 | 22.45 | 26.96 |
PS Ratio | 0.25 | 0.31 | 0.36 | 0.40 | 0.48 | 0.57 |
PB Ratio | 1.60 | 2.00 | 2.27 | 2.59 | 3.79 | 3.91 |
P/TBV Ratio | 1.76 | 2.20 | 2.52 | 2.88 | 4.29 | 4.46 |
P/FCF Ratio | 5.65 | - | 12.51 | - | 3.67 | 15.56 |
P/OCF Ratio | 5.62 | - | 12.42 | - | 3.66 | 15.37 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.22 | 0.40 | 0.36 | 0.38 | 0.39 | 0.66 |
EV/EBITDA Ratio | 8.39 | 16.01 | 11.84 | 13.62 | 11.80 | 23.70 |
EV/EBIT Ratio | 8.98 | 16.56 | 12.24 | 14.15 | 12.20 | 24.73 |
EV/FCF Ratio | 5.04 | - | 12.50 | - | 2.98 | 18.08 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.22 | 0.33 | 0.38 | 0.47 | 0.61 | 0.75 |
Debt / EBITDA Ratio | 1.28 | 1.95 | 1.93 | 2.47 | 2.29 | 3.76 |
Debt / FCF Ratio | 0.77 | - | 2.10 | - | 0.59 | 2.98 |
Net Debt / Equity Ratio | -0.26 | -0.32 | -0.45 | -0.57 | -1.36 | -0.40 |
Net Debt / EBITDA Ratio | -1.57 | -1.94 | -2.37 | -3.11 | -5.22 | -2.11 |
Net Debt / FCF Ratio | -0.91 | 6.89 | -2.50 | 0.96 | -1.32 | -1.61 |
Asset Turnover | 1.66 | 2.14 | 1.83 | 1.71 | 2.13 | 2.01 |
Inventory Turnover | 4.11 | 6.91 | 6.35 | 6.30 | 6.69 | 5.62 |
Quick Ratio | 0.62 | 0.84 | 0.81 | 0.78 | 0.73 | 0.50 |
Current Ratio | 1.33 | 1.47 | 1.37 | 1.31 | 1.29 | 1.31 |
Return on Equity (ROE) | 10.58% | 10.91% | 13.97% | 16.08% | 17.93% | 15.31% |
Return on Assets (ROA) | 2.59% | 3.25% | 3.36% | 2.87% | 4.26% | 3.35% |
Return on Invested Capital (ROIC) | 17.51% | 20.22% | 29.43% | 297.27% | 251.35% | 23.83% |
Return on Capital Employed (ROCE) | 15.50% | 15.50% | 18.30% | 17.40% | 23.20% | 17.90% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.08% | 4.99% | 5.33% | 5.45% | 3.74% | 3.40% |
FCF Yield | 17.71% | -2.31% | 8.00% | -22.98% | 27.24% | 6.43% |
Dividend Yield | 3.09% | 2.56% | 3.37% | 3.19% | 2.08% | 1.51% |
Payout Ratio | 81.31% | 82.94% | 71.31% | 54.90% | 44.84% | 55.61% |
Buyback Yield / Dilution | -0.01% | 0.01% | -0.01% | 0.01% | -0.00% | 0.01% |
Total Shareholder Return | 3.08% | 2.57% | 3.36% | 3.20% | 2.08% | 1.51% |